Drug–gene Interaction Screens Coupled to Tumor Data Analyses Identify the Most Clinically Relevant Cancer Vulnerabilities Driving Sensitivity to PARP Inhibition
Kunzah Jamal(AstraZeneca (United Kingdom)), Josep V. Forment(AstraZeneca (United Kingdom))
Cited by 26
Related Papers
A high‐throughput, flow cytometry‐based method to quantify DNA‐end resection in mammalian cells
|Cytometry Part A|2012|75